|
Characteristics of 2,061 patients with perforated and 7,232 patients with bleeding peptic ulcer in the counties of North Jutland, Aarhus and Viborg, Denmark. |
||||||
| Perforated peptic ulcer |
Bleeding peptic ulcer |
|||||
|
|
||||||
| 15–64 years N |
65–79 years N |
80+ years N |
15–64 years N |
65–79 years N |
80+ years N |
|
|
|
||||||
| Gender |
||||||
| Female |
338 (42.0%) |
410 (55.2%) |
358 (69.8%) |
739 (35.5%) |
1329 (47.1%) |
1402 (59.1%) |
| Male |
467 (58.0%) |
333 (44.8%) |
155 (30.2%) |
1347 (64.6%) |
1445 (52.1%) |
970 (40.9%) |
| Ulcer-related drugs* |
||||||
| Use† |
484 (60.1%) |
554 (74.6%) |
417 (81.3%) |
1434 (68.7%) |
2093 (75.4%) |
1950 (82.2%) |
| No use |
321 (39.9%) |
189 (25.4%) |
96 (18.7%) |
652 (31.3%) |
681 (24.6%) |
422 (17.8%) |
| Previous uncomplicated peptic ulcer disease |
||||||
| No |
709 (88.1%) |
657 (88.4%) |
463 (90.3%) |
1829 (87.5%) |
2446 (88.2%) |
2115 (89.2%) |
| Yes |
96 (11.9%) |
86 (11.6%) |
50 (9.7%) |
257 (12.6%) |
328 (11.8%) |
257 (10.8%) |
| Comorbidity# |
||||||
| Low |
616 (76.5%) |
378 (50.9%) |
273 (53.2%) |
1442 (68.2%) |
1322 (47.7%) |
1148 (48.4%) |
| Moderate |
161 (20.0%) |
290 (39.0%) |
208 (40.6%) |
523 (25.1%) |
1139 (41.0%) |
1013 (42.7%) |
| High |
28 (3.5%) |
75 (10.1%) |
32 (6.2%) |
141 (6.7%) |
313 (11.3%) |
212 (8.9%) |
|
*For perforated peptic ulcer "ulcer-related drugs" are: oral glucocorticoids, NSAIDs and aspirin. For bleeding peptic ulcer "ulcer-related drugs" are: non-aspirin NSAIDs, aspirin, oral glucocorticoids, vitamin K antagonists, calcium channel blockers, and/or antidepressants † Use = filled prescription 60 days before admission with perforated peptic ulcer. # Three levels of the index were defined: Low (no co-morbidity), medium (Charlson index 1–2) and high (Charlson index 2+). | ||||||
Christensen et al. BMC Geriatrics 2007 7:8 doi:10.1186/1471-2318-7-8 |
||||||